Rigor, Reproducibility & STAR Methods (cc-reporting-standards)
When to trigger
- Drafting or auditing the Methods section for a Cell Press submission
- Reviewers may flag unauthenticated cell lines, undefined reagents, or missing deposition
- Need to build the Key Resources Table (KRT) and assign RRIDs
- Animal or sequencing work needs structured rigor reporting
STAR Methods structure
Cell Press uses STAR Methods (Structured, Transparent, Accessible Reporting). Organize methods under standardized headings:
- Key Resources Table (KRT) — at the top; tabulates every critical reagent/resource with source, identifier, and RRID.
- Resource availability — Lead contact; Materials availability (plasmids, cell lines, mouse strains); Data and code availability.
- Experimental model and study participant details — cell lines, animals, human subjects, organoids/PDX provenance.
- Method details — full protocols, reproducible by an expert.
- Quantification and statistical analysis — what test, what
n, what software (links to cc-statistics).
Key Resources Table — what must carry an RRID / identifier
| Category |
Required detail |
| Antibodies |
Host, clone, vendor, catalog #, RRID, dilution/application |
| Cell lines |
Name, sex/origin, source, authentication status, RRID (Cellosaurus) |
| Chemicals / inhibitors |
Vendor, catalog #, identifier |
| Critical kits |
Vendor, catalog # |
| Deposited data |
Repository + accession (GEO/SRA/PRIDE/PDB) |
| Oligos / sgRNAs / primers |
Full sequences |
| Recombinant DNA / plasmids |
Source, Addgene # / RRID |
| Organisms / strains |
Strain, source, RRID (e.g., MGI/JAX) |
| Software / algorithms |
Name, version, URL, RRID |
Cell-line rigor (frequent reviewer target)
- Authenticate human cell lines (STR profiling); reference Cellosaurus; state the source.
- Mycoplasma testing — state that lines were tested negative; give frequency.
- Flag any misidentified/commonly contaminated lines (ICLAC register) and justify use.
- Report passage range and culture conditions enough to reproduce.
Antibody validation
- Give clone, catalog, RRID, and application-specific validation (KO/KD control, single band of expected MW, IHC titration with positive/negative tissue).
- For new/critical antibodies, show validation in the supplement.
Animal reporting (ARRIVE 2.0 essentials)
- Species, strain, sex, age, source; housing and husbandry.
- Sample size rationale; randomization; blinding of outcome assessment.
- Inclusion/exclusion criteria; humane endpoints; number used and analyzed.
- IACUC protocol number and approving institution (statement routed via
cc-ethics-registration).
Data and code availability
- Deposit and cite accessions in the KRT and availability statement:
- Sequencing / arrays → GEO/SRA; controlled human genomics → dbGaP/EGA
- Proteomics → PRIDE; metabolomics → MetaboLights/Workbench
- Structures → PDB (+ EMDB for cryo-EM maps)
- Custom code → versioned public repo with a citable DOI (e.g., Zenodo).
- "Available on request" is unacceptable for these data types.
Worked micro-example: a KRT antibody row before → after
Before (desk-reject-grade entry):
Anti-MARK7 — Abcam — for Western blot
After (STAR-compliant entry):
Rabbit monoclonal anti-MARK7, clone EPR-xxxx, Abcam, Cat# ab000000, RRID:AB_0000000; WB 1:1000,
validated against MARK7-KO lysate (single band at expected MW, Figure S1).
The "after" carries host, clonality, clone ID, vendor, catalog, RRID, application, dilution, and the
validation evidence — every column a Cancer Cell editor scans the KRT for. A reviewer who cannot find
the RRID or the KO/KD validation treats the reagent as unverified.
STAR Methods pre-submission self-check
Walk the Methods in the order an in-house editor will:
- Is the KRT at the top, with a row for every antibody, line, organism, plasmid, oligo, dataset, and software?
- Does Resource availability name the lead contact and state materials + data + code availability explicitly?
- Are cell lines authenticated (STR), mycoplasma-negative, and cross-checked against the ICLAC misidentified-lines register?
- Do animal subsections give species/strain/sex/age, sample-size rationale, randomization, and blinded outcome scoring?
- Are all newly generated large datasets deposited with accessions echoed in both the KRT and the availability statement?
- Is the statistics subsection specific — exact test,
n as biological replicates, multiplicity correction?
Rigor failure modes that draw reviewer or editor flags
- A KRT that lists reagents but omits RRIDs or authentication status.
- Human lines with no STR profile, or a commonly contaminated line used without justification.
- Antibodies validated "by the manufacturer" only, with no in-house KO/KD or titration control.
- Animal work reporting "n mice" with no allocation, blinding, or exclusion criteria.
- Sequencing/proteomics described in Results but with no GEO/PRIDE accession by submission.
- Code described as "custom scripts" with no repository or DOI.
Checklist
Anti-patterns
- Cell lines with no authentication or mycoplasma statement
- Antibodies listed as "anti-X (Abcam)" with no catalog/RRID/validation
- Animal methods with no randomization/blinding/sample-size basis
- Sequencing data "available upon request" with no accession
- Methods too thin to reproduce the experiment
Output format
【STAR Methods】headings complete? KRT present?
【KRT gaps】reagents missing source/RRID: [...]
【Cell-line rigor】authenticated? mycoplasma? contaminated-line flags?
【Antibody validation】adequate / show in supplement: [...]
【Animal rigor】ARRIVE elements present? [...]
【Deposition】GEO/SRA/PRIDE/PDB accessions + code DOI status
【Next step】cc-statistics or cc-ethics-registration
1---2name: cc-reporting-standards3description: Use when assembling STAR Methods and the Key Resources Table for a Cancer Cell (Cell Press) manuscript, and when ensuring rigor / reproducibility (cell-line authentication, mycoplasma, antibody validation, ARRIVE animal reporting, data/code deposition). It governs reporting; it does not design experiments.4metadata:5 source: https://skillmd.com/skills/brycewang-stanford/cc-reporting-standards6---78# Rigor, Reproducibility & STAR Methods (cc-reporting-standards)910## When to trigger1112- Drafting or auditing the Methods section for a Cell Press submission13- Reviewers may flag unauthenticated cell lines, undefined reagents, or missing deposition14- Need to build the Key Resources Table (KRT) and assign RRIDs15- Animal or sequencing work needs structured rigor reporting1617## STAR Methods structure1819Cell Press uses **STAR Methods** (Structured, Transparent, Accessible Reporting). Organize methods under standardized headings:20211. **Key Resources Table (KRT)** — at the top; tabulates every critical reagent/resource with source, identifier, and RRID.222. **Resource availability** — Lead contact; Materials availability (plasmids, cell lines, mouse strains); Data and code availability.233. **Experimental model and study participant details** — cell lines, animals, human subjects, organoids/PDX provenance.244. **Method details** — full protocols, reproducible by an expert.255. **Quantification and statistical analysis** — what test, what `n`, what software (links to `cc-statistics`).2627## Key Resources Table — what must carry an RRID / identifier2829| Category | Required detail |30|----------|-----------------|31| Antibodies | Host, clone, vendor, catalog #, RRID, dilution/application |32| Cell lines | Name, sex/origin, source, authentication status, RRID (Cellosaurus) |33| Chemicals / inhibitors | Vendor, catalog #, identifier |34| Critical kits | Vendor, catalog # |35| Deposited data | Repository + accession (GEO/SRA/PRIDE/PDB) |36| Oligos / sgRNAs / primers | Full sequences |37| Recombinant DNA / plasmids | Source, Addgene # / RRID |38| Organisms / strains | Strain, source, RRID (e.g., MGI/JAX) |39| Software / algorithms | Name, version, URL, RRID |4041## Cell-line rigor (frequent reviewer target)4243- **Authenticate** human cell lines (STR profiling); reference Cellosaurus; state the source.44- **Mycoplasma testing** — state that lines were tested negative; give frequency.45- Flag any misidentified/commonly contaminated lines (ICLAC register) and justify use.46- Report passage range and culture conditions enough to reproduce.4748## Antibody validation4950- Give clone, catalog, RRID, and **application-specific** validation (KO/KD control, single band of expected MW, IHC titration with positive/negative tissue).51- For new/critical antibodies, show validation in the supplement.5253## Animal reporting (ARRIVE 2.0 essentials)5455- Species, strain, sex, age, source; housing and husbandry.56- **Sample size** rationale; **randomization**; **blinding** of outcome assessment.57- Inclusion/exclusion criteria; humane endpoints; number used and analyzed.58- IACUC protocol number and approving institution (statement routed via `cc-ethics-registration`).5960## Data and code availability6162- Deposit and cite accessions in the KRT and availability statement:63 - Sequencing / arrays → **GEO/SRA**; controlled human genomics → **dbGaP/EGA**64 - Proteomics → **PRIDE**; metabolomics → MetaboLights/Workbench65 - Structures → **PDB** (+ **EMDB** for cryo-EM maps)66- Custom code → versioned public repo with a citable DOI (e.g., Zenodo).67- "Available on request" is unacceptable for these data types.6869## Worked micro-example: a KRT antibody row before → after7071**Before (desk-reject-grade entry):**7273> Anti-MARK7 — Abcam — for Western blot7475**After (STAR-compliant entry):**7677> Rabbit monoclonal anti-MARK7, clone EPR-xxxx, Abcam, Cat# ab000000, RRID:AB_0000000; WB 1:1000,78> validated against MARK7-KO lysate (single band at expected MW, Figure S1).7980The "after" carries host, clonality, clone ID, vendor, catalog, RRID, application, dilution, and the81validation evidence — every column a Cancer Cell editor scans the KRT for. A reviewer who cannot find82the RRID or the KO/KD validation treats the reagent as unverified.8384## STAR Methods pre-submission self-check8586Walk the Methods in the order an in-house editor will:87881. Is the **KRT at the top**, with a row for every antibody, line, organism, plasmid, oligo, dataset, and software?892. Does **Resource availability** name the lead contact and state materials + data + code availability explicitly?903. Are **cell lines** authenticated (STR), mycoplasma-negative, and cross-checked against the ICLAC misidentified-lines register?914. Do **animal** subsections give species/strain/sex/age, sample-size rationale, randomization, and blinded outcome scoring?925. Are **all** newly generated large datasets deposited with accessions echoed in both the KRT and the availability statement?936. Is the **statistics** subsection specific — exact test, `n` as biological replicates, multiplicity correction?9495## Rigor failure modes that draw reviewer or editor flags9697- A KRT that lists reagents but omits RRIDs or authentication status.98- Human lines with no STR profile, or a commonly contaminated line used without justification.99- Antibodies validated "by the manufacturer" only, with no in-house KO/KD or titration control.100- Animal work reporting "n mice" with no allocation, blinding, or exclusion criteria.101- Sequencing/proteomics described in Results but with no GEO/PRIDE accession by submission.102- Code described as "custom scripts" with no repository or DOI.103104## Checklist105106- [ ] STAR Methods headings used; KRT at top107- [ ] Every antibody, cell line, organism, plasmid, software has source + RRID108- [ ] Human cell lines STR-authenticated; mycoplasma-negative stated109- [ ] Antibody validation described (and shown for critical ones)110- [ ] Animal section reports sample size, randomization, blinding, exclusions111- [ ] All large datasets deposited; accessions in KRT + availability statement112- [ ] Custom code deposited with DOI113- [ ] Lead contact and materials-availability statements present114115## Anti-patterns116117- Cell lines with no authentication or mycoplasma statement118- Antibodies listed as "anti-X (Abcam)" with no catalog/RRID/validation119- Animal methods with no randomization/blinding/sample-size basis120- Sequencing data "available upon request" with no accession121- Methods too thin to reproduce the experiment122123## Output format124125```126【STAR Methods】headings complete? KRT present?127【KRT gaps】reagents missing source/RRID: [...]128【Cell-line rigor】authenticated? mycoplasma? contaminated-line flags?129【Antibody validation】adequate / show in supplement: [...]130【Animal rigor】ARRIVE elements present? [...]131【Deposition】GEO/SRA/PRIDE/PDB accessions + code DOI status132【Next step】cc-statistics or cc-ethics-registration133```